ObesityCE

This activity is expired and is no longer available for CME credit.

SLIDES-AUDIO LECTURECME

Obesity Forum 2013: CME Meeting Series Highlights

Author(s)/Faculty: W. Timothy Garvey, MD; Robert Kushner, MD, FACP; Christopher D. Still, DO, FACN, FACP
Release Date: 7/15/2014Expiration Date: 7/14/2015
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
Obesity has increased dramatically in the past 20 years, and is considered a health care epidemic in the United States. One-third of adults in the United States are considered obese, having a body mass index (BMI) ≥ 30 kg/m², according to the US Centers for Disease Control and Prevention. Serious health concerns associated with obesity include increased risk for hypertension, stroke, coronary heart disease, dyslipidemia, type 2 diabetes, depression, sleep apnea, osteoarthritis, infertility, as well as cancers of the colon, breast, and endometrium. A BMI of ≥ 35 kg/m², increased waist circumference, and waist-to-hip ratio are predictors of increased risk for mortality. Evidence suggests that losing even 5% of body weight can produce clinically relevant decreases in insulin resistance, decreases in blood pressure, and improvements in lipid profiles. Although some patients will successfully achieve weight loss with changes in diet and exercise alone, these patients represent the minority, and a significant percentage of patients who are successful are unable to maintain weight loss over time. Staying current with evidence-based recommendations for treatment, including knowledge of the safety and efficacy of emerging therapeutic options, is vital to health care practitioners as they work with patients to develop optimal, individualized, long-term strategies for overcoming obesity. The Obesity ForumTM is a full-day CME program, co-sponsored and endorsed by The Obesity Society. This CME program will feature didactic presentations, interactive, audience-driven case-based learning, in addition to addressing the association between obesity and related comorbidities, overcoming barriers in managing overweight patients, as well as discussing the safety, efficacy, and appropriate use of newly approved medications to treat obesity.